DNA testing for hypertrophic cardiomyopathy: a cost-effectiveness model.

DNA testing for hypertrophic cardiomyopathy: a cost-effectiveness model.

Показать другие версии (1)

Aims To explore the cost-effectiveness of alternative methods of screening family members for hypertrophic cardiomyopathy (HCM), the most common monogenic cardiac disorder and the most frequent cause of sudden cardiac death (SCD) in young people. Methods and results Economic decision model comparing...

Полное описание

Библиографические подробности
Главные авторы:	Wordsworth, S, Leal, J, Blair, E, Legood, R, Thomson, K, Seller, A, Taylor, J, Watkins, H
Формат:	Journal article
Язык:	English
Опубликовано:	2010

Схожие документы

Is DNA testing for hypertrophic cardiomyopathy cost-effective?
по: Wordsworth, S, и др.
Опубликовано: (2006)

DNA testing for hypertrophic cardiomyopathy: a cost-effectiveness model
по: Wordsworth, S, и др.
Опубликовано: (2010)

Evaluation of Clinical Diagnostic Potential of Next Generation Sequencing using Hypertrophic Cardiomyopathy as a Model
по: Taylor, J, и др.
Опубликовано: (2010)

A fast-throughput service for Familial Hypertrophic and Dilated Cardiomyopathy using High resolution melt curve analysis on the Lightscanner
по: Thistleton, J, и др.
Опубликовано: (2007)

Expansion of a diagnostic service for hypertrophic cardiomyopathy using next generation sequencing
по: Reid, S, и др.
Опубликовано: (2011)

Linked genetic modifiers in hypertrophic cardiomyopathy
по: Ektisham, J, и др.
Опубликовано: (2004)

Oxford Molecular Genetics Laboratory Cardiomyopathy Service
по: Thistleton, J, и др.
Опубликовано: (2006)

Ascertainment strategies and genotype:phenotype correlations in hypertrophic cardiomyopathy.
по: Blair, E, и др.
Опубликовано: (2003)

Hypertrophic cardiomyopathy:a paradigm for myocardial energy depletion.
по: Ashrafian, H, и др.
Опубликовано: (2003)

Identification of a novel mitochondrial DNA mutation in the ND1 gene in 2 patients with hypertrophic cardiomyopathy with restrictive physiology
по: Khogali, S, и др.
Опубликовано: (2001)

Early onset malignant hypertrophic cardiomyopathy caused by mutations in MYBPC3
по: Carballo, S, и др.
Опубликовано: (2003)

Sudden death in hypertrophic cardiomyopathy.
по: Watkins, H
Опубликовано: (2000)

Myocardial dysfunction in hypertrophic cardiomyopathy.
по: Ashrafian, H, и др.
Опубликовано: (2001)

Novel mutations in cardiac MYBPC3 and early onset malignant hypertrophic cardiomyopathy
по: Carballo, S, и др.
Опубликовано: (2005)

Novel mutations in cardiac MYBPC3 causing early onset malignant hypertrophic cardiomyopathy
по: Carballo, S, и др.
Опубликовано: (2005)

Hypertrophic cardiomyopathy in Noonan Syndrome closely mimics familial hypertrophic cardiomyopathy due to sarcomeric mutations.
по: Hudsmith, L, и др.
Опубликовано: (2006)

Double mutations in CIS can confound genotype-phenotype correlations in hypertrophic cardiomyopathy
по: Blair, E, и др.
Опубликовано: (2000)

Data-driven modelling of mutational hotspots and in silico predictors in hypertrophic cardiomyopathy
по: Waring, A, и др.
Опубликовано: (2020)

Metabolic perturbations in the pathogenesis of hypertrophic cardiomyopathy
по: Ashrafian, H, и др.
Опубликовано: (2005)

Eliciting expert opinion for economic models: an applied example.
по: Leal, J, и др.
Опубликовано: (2007)

Novel mutations in cardiac MYPBC3 cause early onset malignant hypertrophic cardiomyopathy (HCM)
по: Carballo, S, и др.
Опубликовано: (2005)

Mutations in cis can confound genotype-phenotype correlations in hypertrophic cardiomyopathy.
по: Blair, E, и др.
Опубликовано: (2001)

The genetics of hypertrophic cardiomyopathy: Teare redux.
по: Watkins, H, и др.
Опубликовано: (2008)

Experience in genetic testing of hypertrophic cardiomyopathy using nanopore DNA sequencing
по: R. R. Salakhov, и др.
Опубликовано: (2021-11-01)

A novel mutation in phospholamban causes a mixed hypertrophic and dilated cardiomyopathy phenotype with autosomal dominant inheritance
по: Carballo, S, и др.
Опубликовано: (2004)

Genetic clues to disease pathways in hypertrophic and dilated cardiomyopathies.
по: Watkins, H
Опубликовано: (2003)

Functional analysis of hypertrophic cardiomyopathy missense mutations in the light meromyosin region of beta myosin heavy chain
по: Redwood, C, и др.
Опубликовано: (2003)

Identification of a novel mitochondrial NADH dehydrogenase I (MTND1) gene mutation in two patients with hypertrophic cardiomyopathy
по: Khogali, S, и др.
Опубликовано: (2001)

Hypertrophic cardiomyopathy: from molecular and genetic mechanisms to clinical management
по: Watkins, H
Опубликовано: (2001)

Assigning a causal role to genetic variants in hypertrophic cardiomyopathy.
по: Watkins, H
Опубликовано: (2013)

Screening for hypertrophic cardiomyopathy: a cost analysis of echocardiography, cardiac magnetic resonance and genetic testing
по: Manning Warren J, и др.
Опубликовано: (2009-01-01)

The prognostic impact of septal myectomy in obstructive hypertrophic cardiomyopathy.
по: Watkins, H, и др.
Опубликовано: (2005)

Hypertrophic Cardiomyopathy
по: Asra K. Butt, и др.
Опубликовано: (2023-03-01)

Disease pathways and novel therapeutic targets in hypertrophic cardiomyopathy.
по: Ashrafian, H, и др.
Опубликовано: (2011)

Cardiac Steatosis Detected in Hypertrophic Cardiomyopathy, Dilated Cardiomyopathy and Aortic Stenosis
по: Suttie, J, и др.
Опубликовано: (2011)

Private mitochondrial DNA variants in danish patients with hypertrophic cardiomyopathy.
по: Christian M Hagen, и др.
Опубликовано: (2015-01-01)

Hypertrophic cardiomyopathy
по: Sarita Gore, и др.
Опубликовано: (2022-01-01)

Hypertrophic Cardiomyopathy
по: Polakit Teekakirikul, MD, и др.
Опубликовано: (2021-09-01)

Hypertrophic cardiomyopathy
по: Murillo de Oliveira Antunes, и др.
Опубликовано: (2020-04-01)

The Role of Cardiopulmonary Exercise Testing in Hypertrophic Cardiomyopathy
по: Lidija Mikic, и др.
Опубликовано: (2023-07-01)